NCT05335785

Brief Summary

Rotatorcuff lesions constitute 10% of the causes of shoulder pain. Supraspinatus tear is one of the common rotatorcuff lesions. It affects the quality of life negatively and causes loss of range of motion and muscle strength. It can be seen due to traumatic or degenerative causes. Its incidence increases with advanced age. While the incidence was reported as 4% in the population aged 40-60 years, this rate was reported to be 17-50% in the group over the age of 60 and 80% in the group over the age of 80. Radiologically, classification is made as partial or full-thickness tears. Rotatorcuff tears can be treated conservatively or surgically. Although the risk of post-surgical rupture is reduced with new methods, the lack of desired tendon healing has led to the search for alternative applications such as biological augmentation and high-intensity laser. The aim of this study is to reveal the effectiveness of high-intensity laser therapy in patients with partial supraspinatus tear.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2020

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 8, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 19, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2023

Completed
Last Updated

April 19, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

March 8, 2022

Last Update Submit

April 14, 2022

Conditions

Keywords

shouldersupraspinatus tearrotator cuff tearhiltherapylazer therapy

Outcome Measures

Primary Outcomes (1)

  • VAS (visuel analog score)

    evaluation of pain with scale of between 0 and 10 that means 0 no pain and 10 too much pain.

    3rd month

Secondary Outcomes (1)

  • Constant score

    6 th month

Study Arms (3)

5 session lazer therapy

ACTIVE COMPARATOR

30 patients will be included to 5 session lazer therapy group. They will take totally 5 sessions of high-intensity laser every other day.

Device: High-intensity lazer therapy

10 session lazer therapy

ACTIVE COMPARATOR

30 patients will be included to 10 session lazer therapy group. They will take totally 10 sessions of high-intensity laser every other day.

Device: High-intensity lazer therapy

control group

OTHER

30 patients will be included to control group. They will take only exercise program three times in a week.

Other: Exercises

Interventions

Patients in the laser group will be given hiltherapy (high-intensity laser) with the HIRO 3 device every other day. One session of laser therapy application consists of 3 phases: the beginning, the middle and the ending phase. The initial phases are fast scanning and the ending phase is slow scanning. A total of 2000 J will be applied to the rotatorcuff muscles, the upper part of the trapezius muscle, the deltoid muscle and the pectoralis major muscle, 1000 J in the rapid scan phase and 1000 J in the finishing phase. In the middle phase, 50 J will be applied for the trigger point (hard intramuscular points that cause referred pain) in each muscle and a maximum of 500 J in total. The total dose prescribed for patients in one session will be 2500 J. Each phase will be 15 minutes on average and the session will last for 45 minutes in total. The laser probe will be applied with 90 degrees. During the application, the practitioner and the patient will have protective glasses.

10 session lazer therapy5 session lazer therapy

Exercise program including Codman, Range of motion and streightening exercises three times in a week.

control group

Eligibility Criteria

Age20 Years - 65 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 20-65 years
  • Patients with VAS\>4 pain in the shoulder for at least 3 months
  • Patients with at least 25% loss in the range of motion of the joint compared to the contralateral side, especially in abduction and external rotation, or on physical examination or positivity of at least one of the impingement tests including jobb, lift off, ERLS , speed, yergeson, O Brien's test, dropparm tests or popeye signs.
  • Diagnose of partial supraspinatus with ultrasound or MR

You may not qualify if:

  • Patients with incomplete skin integrity, hyperemia, signs of infection or tattoos
  • Patients with suspected full-thickness tear
  • History of rheumatic disease (rheumatoidarthritis, osteoarthritis, PMR)
  • Patients with accompanying shoulder pathology such as calcifictendinitis
  • History of malignancy
  • Surgery, manipulation, mobilization, arthroscopy performed on the affected shoulder
  • Steroid, local anesthetic, hyaluronic acid injection, cnesiotaping or neural therapy in the affected shoulder in the last 3 months
  • Reflex sympathetic dystrophy, neurodeficit in the affected extremity
  • Diabetes patients or any Patients who cannot feel the burning pain due to a peripheral neuropathy or sensory defect
  • Patients with epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Katip Celebi University

Izmir, Karabaglar, 35360, Turkey (Türkiye)

Location

Related Publications (5)

  • Meislin RJ, Sperling JW, Stitik TP. Persistent shoulder pain: epidemiology, pathophysiology, and diagnosis. Am J Orthop (Belle Mead NJ). 2005 Dec;34(12 Suppl):5-9.

    PMID: 16450690BACKGROUND
  • Boileau P, Brassart N, Watkinson DJ, Carles M, Hatzidakis AM, Krishnan SG. Arthroscopic repair of full-thickness tears of the supraspinatus: does the tendon really heal? J Bone Joint Surg Am. 2005 Jun;87(6):1229-40. doi: 10.2106/JBJS.D.02035.

    PMID: 15930531BACKGROUND
  • Elsodany AM, Alayat MSM, Ali MME, Khaprani HM. Long-Term Effect of Pulsed Nd:YAG Laser in the Treatment of Patients with Rotator Cuff Tendinopathy: A Randomized Controlled Trial. Photomed Laser Surg. 2018 Sep;36(9):506-513. doi: 10.1089/pho.2018.4476.

    PMID: 30188253BACKGROUND
  • Haslerud S, Magnussen LH, Joensen J, Lopes-Martins RA, Bjordal JM. The efficacy of low-level laser therapy for shoulder tendinopathy: a systematic review and meta-analysis of randomized controlled trials. Physiother Res Int. 2015 Jun;20(2):108-25. doi: 10.1002/pri.1606. Epub 2014 Dec 2.

    PMID: 25450903BACKGROUND
  • Aleem AW, Brophy RH. Outcomes of rotator cuff surgery: what does the evidence tell us? Clin Sports Med. 2012 Oct;31(4):665-74. doi: 10.1016/j.csm.2012.07.004.

    PMID: 23040552BACKGROUND

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Exercise

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Korhan Barış Bayram, assoc. prof.

    Katip Celebi University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor doctor

Study Record Dates

First Submitted

March 8, 2022

First Posted

April 19, 2022

Study Start

December 2, 2020

Primary Completion

December 2, 2022

Study Completion

December 2, 2023

Last Updated

April 19, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

study protocol will be shared for first 6 months after the study finish results and statisitcs will be shared.

Shared Documents
STUDY PROTOCOL
Time Frame
when the study start and data will be avaliable for 6 months
Access Criteria
study protocol will be shared for first 6 months after the study finish results and statisitcs will be shared.

Locations